Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist

Although the prevalence of heart failure has been increasing over time, the presentation of heart failure has been shifting, with a greater proportion of preserved ejection fraction and more slowly progressive symptoms that require recognition in the outpatient setting. These shifts have placed more...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes, obesity & metabolism obesity & metabolism, 2023-07, Vol.25 (S3), p.15-25
1. Verfasser: Arnold, Suzanne V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 25
container_issue S3
container_start_page 15
container_title Diabetes, obesity & metabolism
container_volume 25
creator Arnold, Suzanne V.
description Although the prevalence of heart failure has been increasing over time, the presentation of heart failure has been shifting, with a greater proportion of preserved ejection fraction and more slowly progressive symptoms that require recognition in the outpatient setting. These shifts have placed more of the diagnostic responsibility onto primary care physicians, who often are challenged to determine the etiology of common symptoms in patients who often have several other potential reasons for these symptoms. Establishing a diagnosis of heart failure requires a step‐wise approach that includes physical exam (looking for multiple signs of hypervolemia), labs (B‐type natriuretic peptide levels), and echocardiography (structural and functional measures). Diagnostic algorithms are particularly challenging in patients with obesity, which limits the assessment of intravascular volume on exam, the quality of cardiac imaging, and the diagnostic accuracy of B‐type natriuretic peptide levels, which may be falsely low. In these challenging patients, the use of risk scores, invasive testing of intravascular volume, or empiric treatment of hypervolemia may be needed to determine whether symptoms are due to heart failure. Once a diagnosis of heart failure is established, several treatments can be beneficial, from diuretics to relieve congestion to various aspects of guideline‐directed medical therapy, some of which vary according to the ejection fraction of the patient. In addition, a diagnosis of heart failure may alter the treatment plan for comorbidities, including selection of anti‐hypertensive and glucose‐lowering medications, and medical or surgical treatments for obesity. While a diagnosis of heart failure may be challenging in many patients with slowly progressive and non‐specific symptoms, early recognition and treatment can be extremely effective at preventing hospitalizations, prolonging survival, and improving quality of life.
doi_str_mv 10.1111/dom.15166
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2827921012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2827921012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-a1b95493e2d96216ab8b468b43d1c4910195607074b4d0567362f922c5ad673c3</originalsourceid><addsrcrecordid>eNp1kctKxDAUhoMo3he-gATc6KKaS5u07gbvoMxG1yVtUidj24w5KTI7H8Fn9EmMM6MLwUDIOeTj43B-hA4oOaXxnGnXndKMCrGGtmkqeEI5E-uLmiV5QdgW2gGYEkJSnstNtMUl51JmbBtNRwAGoDN9wK7BYWLwTAX73b7ZMMETo3zAjbLt4A2GeTcLrgOseo29hZf4Uwfn4RyP8PNgtcGN8wtL7_rP949aeW1d654thD200agWzP7q3UVP11ePF7fJ_fjm7mJ0n9Q84yJRtCqytOCG6UIwKlSVV6mIl2tapwUltMgEkUSmVapJJiQXrCkYqzOlY1PzXXS89M68ex0MhLKzUJu2Vb1xA5QsZ7Jg0cMievQHnbrB93G6SPE87lTmWaROllTtHYA3TTnztlN-XlJSfgdQxgDKRQCRPVwZh6oz-pf82XgEzpbAm23N_H9TeTl-WCq_ACSAjuo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2838151785</pqid></control><display><type>article</type><title>Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Arnold, Suzanne V.</creator><creatorcontrib>Arnold, Suzanne V.</creatorcontrib><description>Although the prevalence of heart failure has been increasing over time, the presentation of heart failure has been shifting, with a greater proportion of preserved ejection fraction and more slowly progressive symptoms that require recognition in the outpatient setting. These shifts have placed more of the diagnostic responsibility onto primary care physicians, who often are challenged to determine the etiology of common symptoms in patients who often have several other potential reasons for these symptoms. Establishing a diagnosis of heart failure requires a step‐wise approach that includes physical exam (looking for multiple signs of hypervolemia), labs (B‐type natriuretic peptide levels), and echocardiography (structural and functional measures). Diagnostic algorithms are particularly challenging in patients with obesity, which limits the assessment of intravascular volume on exam, the quality of cardiac imaging, and the diagnostic accuracy of B‐type natriuretic peptide levels, which may be falsely low. In these challenging patients, the use of risk scores, invasive testing of intravascular volume, or empiric treatment of hypervolemia may be needed to determine whether symptoms are due to heart failure. Once a diagnosis of heart failure is established, several treatments can be beneficial, from diuretics to relieve congestion to various aspects of guideline‐directed medical therapy, some of which vary according to the ejection fraction of the patient. In addition, a diagnosis of heart failure may alter the treatment plan for comorbidities, including selection of anti‐hypertensive and glucose‐lowering medications, and medical or surgical treatments for obesity. While a diagnosis of heart failure may be challenging in many patients with slowly progressive and non‐specific symptoms, early recognition and treatment can be extremely effective at preventing hospitalizations, prolonging survival, and improving quality of life.</description><identifier>ISSN: 1462-8902</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/dom.15166</identifier><identifier>PMID: 37337752</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>cardiovascular disease ; Comorbidity ; Congestive heart failure ; Diabetes ; Diagnosis ; Diuretics ; Echocardiography ; Ejection fraction ; Heart failure ; Heart Failure - diagnosis ; Heart Failure - epidemiology ; Heart Failure - etiology ; Humans ; Natriuretic Peptide, Brain ; Obesity ; Obesity - complications ; Patients ; Peptides ; Primary care ; Quality of Life ; Risk factors ; Stroke Volume ; Structure-function relationships ; type 2 diabetes</subject><ispartof>Diabetes, obesity &amp; metabolism, 2023-07, Vol.25 (S3), p.15-25</ispartof><rights>2023 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-a1b95493e2d96216ab8b468b43d1c4910195607074b4d0567362f922c5ad673c3</citedby><cites>FETCH-LOGICAL-c3536-a1b95493e2d96216ab8b468b43d1c4910195607074b4d0567362f922c5ad673c3</cites><orcidid>0000-0003-3367-0302</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdom.15166$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdom.15166$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37337752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arnold, Suzanne V.</creatorcontrib><title>Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist</title><title>Diabetes, obesity &amp; metabolism</title><addtitle>Diabetes Obes Metab</addtitle><description>Although the prevalence of heart failure has been increasing over time, the presentation of heart failure has been shifting, with a greater proportion of preserved ejection fraction and more slowly progressive symptoms that require recognition in the outpatient setting. These shifts have placed more of the diagnostic responsibility onto primary care physicians, who often are challenged to determine the etiology of common symptoms in patients who often have several other potential reasons for these symptoms. Establishing a diagnosis of heart failure requires a step‐wise approach that includes physical exam (looking for multiple signs of hypervolemia), labs (B‐type natriuretic peptide levels), and echocardiography (structural and functional measures). Diagnostic algorithms are particularly challenging in patients with obesity, which limits the assessment of intravascular volume on exam, the quality of cardiac imaging, and the diagnostic accuracy of B‐type natriuretic peptide levels, which may be falsely low. In these challenging patients, the use of risk scores, invasive testing of intravascular volume, or empiric treatment of hypervolemia may be needed to determine whether symptoms are due to heart failure. Once a diagnosis of heart failure is established, several treatments can be beneficial, from diuretics to relieve congestion to various aspects of guideline‐directed medical therapy, some of which vary according to the ejection fraction of the patient. In addition, a diagnosis of heart failure may alter the treatment plan for comorbidities, including selection of anti‐hypertensive and glucose‐lowering medications, and medical or surgical treatments for obesity. While a diagnosis of heart failure may be challenging in many patients with slowly progressive and non‐specific symptoms, early recognition and treatment can be extremely effective at preventing hospitalizations, prolonging survival, and improving quality of life.</description><subject>cardiovascular disease</subject><subject>Comorbidity</subject><subject>Congestive heart failure</subject><subject>Diabetes</subject><subject>Diagnosis</subject><subject>Diuretics</subject><subject>Echocardiography</subject><subject>Ejection fraction</subject><subject>Heart failure</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - epidemiology</subject><subject>Heart Failure - etiology</subject><subject>Humans</subject><subject>Natriuretic Peptide, Brain</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Patients</subject><subject>Peptides</subject><subject>Primary care</subject><subject>Quality of Life</subject><subject>Risk factors</subject><subject>Stroke Volume</subject><subject>Structure-function relationships</subject><subject>type 2 diabetes</subject><issn>1462-8902</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxDAUhoMo3he-gATc6KKaS5u07gbvoMxG1yVtUidj24w5KTI7H8Fn9EmMM6MLwUDIOeTj43B-hA4oOaXxnGnXndKMCrGGtmkqeEI5E-uLmiV5QdgW2gGYEkJSnstNtMUl51JmbBtNRwAGoDN9wK7BYWLwTAX73b7ZMMETo3zAjbLt4A2GeTcLrgOseo29hZf4Uwfn4RyP8PNgtcGN8wtL7_rP949aeW1d654thD200agWzP7q3UVP11ePF7fJ_fjm7mJ0n9Q84yJRtCqytOCG6UIwKlSVV6mIl2tapwUltMgEkUSmVapJJiQXrCkYqzOlY1PzXXS89M68ex0MhLKzUJu2Vb1xA5QsZ7Jg0cMievQHnbrB93G6SPE87lTmWaROllTtHYA3TTnztlN-XlJSfgdQxgDKRQCRPVwZh6oz-pf82XgEzpbAm23N_H9TeTl-WCq_ACSAjuo</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Arnold, Suzanne V.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3367-0302</orcidid></search><sort><creationdate>202307</creationdate><title>Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist</title><author>Arnold, Suzanne V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-a1b95493e2d96216ab8b468b43d1c4910195607074b4d0567362f922c5ad673c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>cardiovascular disease</topic><topic>Comorbidity</topic><topic>Congestive heart failure</topic><topic>Diabetes</topic><topic>Diagnosis</topic><topic>Diuretics</topic><topic>Echocardiography</topic><topic>Ejection fraction</topic><topic>Heart failure</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - epidemiology</topic><topic>Heart Failure - etiology</topic><topic>Humans</topic><topic>Natriuretic Peptide, Brain</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Patients</topic><topic>Peptides</topic><topic>Primary care</topic><topic>Quality of Life</topic><topic>Risk factors</topic><topic>Stroke Volume</topic><topic>Structure-function relationships</topic><topic>type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arnold, Suzanne V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arnold, Suzanne V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist</atitle><jtitle>Diabetes, obesity &amp; metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2023-07</date><risdate>2023</risdate><volume>25</volume><issue>S3</issue><spage>15</spage><epage>25</epage><pages>15-25</pages><issn>1462-8902</issn><eissn>1463-1326</eissn><abstract>Although the prevalence of heart failure has been increasing over time, the presentation of heart failure has been shifting, with a greater proportion of preserved ejection fraction and more slowly progressive symptoms that require recognition in the outpatient setting. These shifts have placed more of the diagnostic responsibility onto primary care physicians, who often are challenged to determine the etiology of common symptoms in patients who often have several other potential reasons for these symptoms. Establishing a diagnosis of heart failure requires a step‐wise approach that includes physical exam (looking for multiple signs of hypervolemia), labs (B‐type natriuretic peptide levels), and echocardiography (structural and functional measures). Diagnostic algorithms are particularly challenging in patients with obesity, which limits the assessment of intravascular volume on exam, the quality of cardiac imaging, and the diagnostic accuracy of B‐type natriuretic peptide levels, which may be falsely low. In these challenging patients, the use of risk scores, invasive testing of intravascular volume, or empiric treatment of hypervolemia may be needed to determine whether symptoms are due to heart failure. Once a diagnosis of heart failure is established, several treatments can be beneficial, from diuretics to relieve congestion to various aspects of guideline‐directed medical therapy, some of which vary according to the ejection fraction of the patient. In addition, a diagnosis of heart failure may alter the treatment plan for comorbidities, including selection of anti‐hypertensive and glucose‐lowering medications, and medical or surgical treatments for obesity. While a diagnosis of heart failure may be challenging in many patients with slowly progressive and non‐specific symptoms, early recognition and treatment can be extremely effective at preventing hospitalizations, prolonging survival, and improving quality of life.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>37337752</pmid><doi>10.1111/dom.15166</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-3367-0302</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1462-8902
ispartof Diabetes, obesity & metabolism, 2023-07, Vol.25 (S3), p.15-25
issn 1462-8902
1463-1326
language eng
recordid cdi_proquest_miscellaneous_2827921012
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects cardiovascular disease
Comorbidity
Congestive heart failure
Diabetes
Diagnosis
Diuretics
Echocardiography
Ejection fraction
Heart failure
Heart Failure - diagnosis
Heart Failure - epidemiology
Heart Failure - etiology
Humans
Natriuretic Peptide, Brain
Obesity
Obesity - complications
Patients
Peptides
Primary care
Quality of Life
Risk factors
Stroke Volume
Structure-function relationships
type 2 diabetes
title Assessment of the patient with heart failure symptoms and risk factors: A guide for the non‐cardiologist
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T16%3A39%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20patient%20with%20heart%20failure%20symptoms%20and%20risk%20factors:%20A%20guide%20for%20the%20non%E2%80%90cardiologist&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Arnold,%20Suzanne%20V.&rft.date=2023-07&rft.volume=25&rft.issue=S3&rft.spage=15&rft.epage=25&rft.pages=15-25&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/dom.15166&rft_dat=%3Cproquest_cross%3E2827921012%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2838151785&rft_id=info:pmid/37337752&rfr_iscdi=true